• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Serum markers for early diagnosis of fulminant type 1 diabetes

Research Project

Project/Area Number 15K09402
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Metabolomics
Research InstitutionOsaka Medical College

Principal Investigator

Hanafusa Toshiaki  大阪医科大学, その他部局等, 名誉教授 (60164886)

Co-Investigator(Kenkyū-buntansha) 佐野 寛行  大阪医科大学, 医学部, 助教 (20556435)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords劇症1型糖尿病 / 抗CD300e抗体 / Seromic analysis / 抗CD300e抗体 / Seromic analysis / 抗CD300e抗体 / 新規抗体
Outline of Final Research Achievements

The present study clarified a novel biomarker anti-CD300e antibody to diagnose fulminant type 1 diabetes (FT1D). Seromic analysis revealed 9 antibodies which showed high signals in sera from patients with FT1D in acute phase. Among them, the titre of anti-CD300e antibody was significantly higher in FT1D patients in acute phase than that in autoimmune type 1 diabetes (T1AD), type 2 diabetes (T2D), autoimmune thyroid disease (AITD) patients and healthy controls (HC) by ELISA.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (3 results)

All 2018 2016 2015

All Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results,  Acknowledgement Compliant: 1 results) Presentation (2 results)

  • [Journal Article] Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes.2016

    • Author(s)
      Haseda F, Imagawa A, Nishikawa H, Mitsui S, Tsutsumi C, Fujisawa R, Sano H, Murase-Mishiba Y, Terasaki J, Sakaguchi S, Hanafusa T.
    • Journal Title

      PLOS ONE

      Volume: 11 Issue: 8 Pages: e0160576-e0160576

    • DOI

      10.1371/journal.pone.0160576

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Presentation] 劇症1型糖尿病患者急性期血清において上昇を認めた新規抗体、抗CD300e抗体2018

    • Author(s)
      長谷田文孝、西川博嘉、三井しのぶ、堤千春、藤澤玲子、佐野寛行、三柴裕子、寺前純吾、坂口志文、花房俊昭、今川彰久、
    • Organizer
      第61回日本糖尿病学会 年次学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 劇症1型糖尿病患者急性期血清において高値を認める新規抗体2015

    • Author(s)
      長谷田文孝、今川彰久、西川博嘉、三井しのぶ、藤澤玲子、堤千春、佐野寛行、三柴裕子、寺前純吾、坂口志文、花房俊昭
    • Organizer
      第58回日本糖尿病学会 年次学術集会
    • Place of Presentation
      ぱしふぃっくびいなす(山口県下関市)
    • Year and Date
      2015-05-21
    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi